Align Technology (ALGN) Competitors

Align Technology logo
$164.04 +0.58 (+0.35%)
As of 01:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? Align Technology's main competitors and comparable companies include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Align Technology compare to DexCom?

DexCom (NASDAQ:DXCM) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

97.8% of DexCom shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DexCom$4.66B6.56$836.30M$2.5532.17
Align Technology$4.03B2.86$410.35M$6.8723.79

In the previous week, DexCom had 5 more articles in the media than Align Technology. MarketBeat recorded 10 mentions for DexCom and 5 mentions for Align Technology. Align Technology's average media sentiment score of 1.41 beat DexCom's score of 0.84 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DexCom
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Align Technology
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

DexCom has a net margin of 19.42% compared to Align Technology's net margin of 11.83%. DexCom's return on equity of 37.77% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
DexCom19.42% 37.77% 15.98%
Align Technology 11.83%15.96%10.48%

DexCom currently has a consensus price target of $95.50, indicating a potential upside of 16.41%. Align Technology has a consensus price target of $193.08, indicating a potential upside of 18.12%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DexCom
0 Sell rating(s)
2 Hold rating(s)
24 Buy rating(s)
2 Strong Buy rating(s)
3.00
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

DexCom has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, meaning that its stock price is 74% more volatile than the broader market.

Summary

DexCom beats Align Technology on 12 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

HealthEquity has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, meaning that its share price is 74% more volatile than the broader market.

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B6.41$215.20M$2.7736.77
Align Technology$4.03B2.86$410.35M$6.8723.79

In the previous week, Align Technology had 3 more articles in the media than HealthEquity. MarketBeat recorded 5 mentions for Align Technology and 2 mentions for HealthEquity. Align Technology's average media sentiment score of 1.41 beat HealthEquity's score of 1.05 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

HealthEquity presently has a consensus target price of $113.53, suggesting a potential upside of 11.48%. Align Technology has a consensus target price of $193.08, suggesting a potential upside of 18.12%. Given Align Technology's higher probable upside, analysts clearly believe Align Technology is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

HealthEquity has a net margin of 17.36% compared to Align Technology's net margin of 11.83%. Align Technology's return on equity of 15.96% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.36% 15.33% 9.51%
Align Technology 11.83%15.96%10.48%

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Align Technology beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

In the previous week, Henry Schein had 10 more articles in the media than Align Technology. MarketBeat recorded 15 mentions for Henry Schein and 5 mentions for Align Technology. Align Technology's average media sentiment score of 1.41 beat Henry Schein's score of 0.36 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
2 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Align Technology
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Align Technology has lower revenue, but higher earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$13.18B0.70$398M$3.6522.72
Align Technology$4.03B2.86$410.35M$6.8723.79

Align Technology has a net margin of 11.83% compared to Henry Schein's net margin of 3.07%. Henry Schein's return on equity of 16.39% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein3.07% 16.39% 5.58%
Align Technology 11.83%15.96%10.48%

Henry Schein has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, indicating that its share price is 74% more volatile than the broader market.

Henry Schein presently has a consensus target price of $93.86, indicating a potential upside of 13.16%. Align Technology has a consensus target price of $193.08, indicating a potential upside of 18.12%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Henry Schein.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

Summary

Align Technology beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Medpace (NASDAQ:MEDP) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

In the previous week, Align Technology had 2 more articles in the media than Medpace. MarketBeat recorded 5 mentions for Align Technology and 3 mentions for Medpace. Align Technology's average media sentiment score of 1.41 beat Medpace's score of 1.17 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Medpace currently has a consensus price target of $649.27, suggesting a potential downside of 0.58%. Align Technology has a consensus price target of $193.08, suggesting a potential upside of 18.12%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.23
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

78.0% of Medpace shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Medpace has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, meaning that its stock price is 74% more volatile than the broader market.

Medpace has a net margin of 18.24% compared to Align Technology's net margin of 11.83%. Medpace's return on equity of 99.76% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace18.24% 99.76% 24.47%
Align Technology 11.83%15.96%10.48%

Medpace has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.53B7.22$451.12M$18.0436.20
Align Technology$4.03B2.86$410.35M$6.8723.79

Summary

Align Technology beats Medpace on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Quanterix (NASDAQ:QTRX) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

Align Technology has a net margin of 11.83% compared to Quanterix's net margin of -75.05%. Align Technology's return on equity of 15.96% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Quanterix-75.05% -30.49% -22.44%
Align Technology 11.83%15.96%10.48%

Quanterix has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.74, indicating that its share price is 74% more volatile than the broader market.

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quanterix$138.90M0.98-$107.15M-$2.36N/A
Align Technology$4.03B2.86$410.35M$6.8723.79

86.5% of Quanterix shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.5% of Quanterix shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Quanterix presently has a consensus price target of $3.50, suggesting a potential upside of 22.38%. Align Technology has a consensus price target of $193.08, suggesting a potential upside of 18.12%. Given Quanterix's higher possible upside, analysts plainly believe Quanterix is more favorable than Align Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quanterix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Align Technology
0 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.59

In the previous week, Align Technology had 1 more articles in the media than Quanterix. MarketBeat recorded 5 mentions for Align Technology and 4 mentions for Quanterix. Align Technology's average media sentiment score of 1.41 beat Quanterix's score of 0.40 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quanterix
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Align Technology
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Align Technology beats Quanterix on 14 of the 16 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALGN vs. The Competition

MetricAlign TechnologyHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$11.57B$5.96B$7.66B$11.73B
Dividend YieldN/A1.68%2.47%4.46%
P/E Ratio23.8838.9634.0030.04
Price / Sales2.875.458.445.70
Price / Cash13.9823.6221.0121.90
Price / Book2.694.244.483.75
Net Income$410.35M$143.92M$3.51B$394.12M
7 Day Performance-4.67%-5.22%-5.93%-5.63%
1 Month Performance11.36%-3.34%-4.31%-6.93%
1 Year Performance24.01%0.43%-1.15%-7.12%

Align Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALGN
Align Technology
3.86 of 5 stars
$164.04
+0.4%
$193.08
+17.7%
+23.3%$11.57B$4.03B23.8820,290
DXCM
DexCom
3.842 of 5 stars
$81.07
+2.1%
$95.50
+17.8%
+40.3%$33.00B$4.66B33.1411,000
HQY
HealthEquity
3.7665 of 5 stars
$102.11
-1.5%
$113.53
+11.2%
+1.7%$9.00B$1.31B36.862,814
HSIC
Henry Schein
2.532 of 5 stars
$88.41
+2.7%
$93.57
+5.8%
+16.4%$9.75B$13.18B24.2225,000
MEDP
Medpace
2.5717 of 5 stars
$672.93
+3.0%
$649.27
-3.5%
+11.5%$18.37B$2.53B36.416,200

Related Companies and Tools


This page (NASDAQ:ALGN) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners